None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Patients aged 65 or older and hospitalized for acute symptoms. ? Patients with confirmed senility or pre-aging (KFRAIL 1 point or more) ? High blood pressure, diabetes, ischemic heart disease, chronic lung disease, arthritis, cerebral infarction, depression, chronic kidney disease, dementia, cerebral infarction, etc. among the following diseases. ? A person who has lived in a house other than a nursing home for at least 3 months before hospitalization. ? Since local treatment surgery, radiation chemotherapy, radiation therapy, etc. for radical purposes are impossible, patient stage 3 or higher, which is subject to informal primary chemotherapy. ? Histologically confirmed as cancer, gastric adenocarcinoma, colon adenocarcinoma, lung cancer, non-small cells, small cell carcinoma, pancreatic adenocarcinoma, biliary tract adenocarcinoma
Exclusion criteria
Exclusion criteria: ? When hospitalization is required in a special ward, such as an internal medicine intensive care unit, a cardiovascular intensive care unit, or an acute stroke ward, at the time of hospitalization. ? Patients who are not subject to conventional first-line chemotherapy. ? Patients who are subject to oral targeted therapy with conventional primary treatment. ? In the case where palliative hospice palliative care is required due to a terminal disease ? If your life expectancy is less than 6 months ? Patients who recur within 6 months of completion of assisted chemotherapy for the purpose of preventing recurrence after surgery. ? In the case where there are other serious reasons for restricting participation and progress of research at the discretion of the researcher
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Entering a long term care facility (nursing home, long term care hospital and etc) within 3 months after discharge;Geriatric syndrome during hospitalization;Validation of anticancer drug toxicity prediction model;reduce in total number of medications or inappropriate medication;Degree of recognition of advance directive;changes in sarcopenic obesity;All-casue mortality;Economic evaluation;Quality of Life;length of living at home;Visit to emergency room after disrcharge | — |
Primary
| Measure | Time frame |
|---|---|
| Overall treatment utility | — |
Countries
Korea, Republic of
Contacts
Chung-Ang Univerisity Hospital